Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer is a research paper published in JCI Insight (2020). On theSindex it has a DataRank of 2.2. It has been cited 62 times, with 47 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.621
From this paper's citation signal
Citation Network Contribution
1.6
From 45 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 47 citers.
NCI
Grant: R35CA197603
National Institutes of Health
Grant: R35
National Institutes of Health
Grant: CA238471
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: R01 CA208328
NCI NIH HHS
Grant: R01 CA238471
NIGMS NIH HHS
Grant: T32 GM008169
NCI NIH HHS
Grant: P30 CA138292
National Institutes of Health
Grant: 5P30CA138292-11
Winship Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 1R35CA197603-01A1
Harnessing Host Response to Prevent Myeloma
National Institutes of Health
Grant: 5R01CA208328-05
Implications of Metabolic Regulation of BCL-2 Dependence for Myeloma Therapy
National Institutes of Health
Grant: 5R01CA238471-02
B cells in autoimmunity following checkpoint blockade therapy
FWCI
3.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals